Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

74thpctl

Volume

0.07×avg

Market Cap

26.62MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Continue with finqOS

Explore Athira Pharma, Inc.'s financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Athira Pharma, Inc.

ATHANASDAQ Global Select·USD·Closed

Athira Pharma, Inc.

ATHANASDAQ·USD·Closed

$6.75

−6.12%

$6.75

−$0.44 (6.12%)

52W Range

74thpctl

Volume

0.07×avg

Mkt Cap

26.62MUSD

P/E

-0.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

ATHA: Athira Pharma, Inc. Financial Statements & Revenue | finqOS